Review
. 2016 Oct;5(12).
doi: 10.1002/cam4.943.

Progress in the clinical detection of heterogeneity in breast cancer

Jun-Long Song 1 Chuang Chen 1 Jing-Ping Yuan 2 Sheng-Rong Sun 1 
Affiliations
  • PMID: 27774765
  •     130 References
  •     16 citations

Abstract

Breast cancer is currently the most common form of cancer and the second-leading cause of death from cancer in women. Though considerable progress has been made in the treatment of breast cancer, the heterogeneity of tumors (both inter- and intratumor) remains a considerable diagnostic and prognostic challenge. From clinical observation to genetic mutations, the history of understanding the heterogeneity of breast cancer is lengthy and detailed. Effectively detecting heterogeneity in breast cancer is important during treatment. Various methods of depicting this heterogeneity are now available and include genetic, pathologic, and imaging analysis. These methods allow characterization of the heterogeneity of breast cancer on a genetic level, providing greater insight during the process of establishing an effective therapeutic plan. This study reviews how the understanding of tumor heterogeneity in breast cancer evolved, and further summarizes recent advances in the detection and monitoring of this heterogeneity in patients with breast cancer.

Keywords: Breast cancer; genomic analysis; heterogeneity; imaging analysis; pathologic analysis.

Expanding the computational toolbox for mining cancer genomes.
Li Ding, Michael C Wendl, Joshua F McMichael, Benjamin J Raphael.
Nat Rev Genet, 2014 Jul 09; 15(8). PMID: 25001846    Free PMC article.
Highly Cited. Review.
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer.
Jin-Zhong Sun, Chuang Chen, +3 authors, Sheng-Rong Sun.
Int J Nanomedicine, 2014 Mar 22; 9. PMID: 24648732    Free PMC article.
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.
G Gebhart, L E Lamberts, +17 authors, P Flamen.
Ann Oncol, 2015 Nov 26; 27(4). PMID: 26598545
Highly Cited.
Subtype classification for prediction of prognosis of breast cancer from a biomarker panel: correlations and indications.
Chuang Chen, Jing-Ping Yuan, +6 authors, Yan Li.
Int J Nanomedicine, 2014 Mar 05; 9. PMID: 24591826    Free PMC article.
RNA-Seq: a revolutionary tool for transcriptomics.
Zhong Wang, Mark Gerstein, Michael Snyder.
Nat Rev Genet, 2008 Nov 19; 10(1). PMID: 19015660    Free PMC article.
Highly Cited. Review.
Three-dimensional contrast-enhanced sonography in the assessment of breast tumor angiogenesis: correlation with microvessel density and vascular endothelial growth factor expression.
Man Chen, Wen-ping Wang, +4 authors, Xiao-chun Fei.
J Ultrasound Med, 2014 Apr 26; 33(5). PMID: 24764339
The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
Peter J Campbell, Shinichi Yachida, +22 authors, P Andrew Futreal.
Nature, 2010 Oct 29; 467(7319). PMID: 20981101    Free PMC article.
Highly Cited.
The landscape of cancer genes and mutational processes in breast cancer.
Philip J Stephens, Patrick S Tarpey, +60 authors, Michael R Stratton.
Nature, 2012 Jun 23; 486(7403). PMID: 22722201    Free PMC article.
Highly Cited.
Cancer whole-genome sequencing: present and future.
H Nakagawa, C P Wardell, +2 authors, A Fujimoto.
Oncogene, 2015 Mar 31; 34(49). PMID: 25823020
Review.
Shear-wave elastography and immunohistochemical profiles in invasive breast cancer: evaluation of maximum and mean elasticity values.
Sergi Ganau, Francisco Javier Andreu, +7 authors, Melcior Sentís.
Eur J Radiol, 2015 Jan 27; 84(4). PMID: 25619502
Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy.
Anna G Sorace, Reshu Saini, Marshall Mahoney, Kenneth Hoyt.
J Ultrasound Med, 2012 Sep 27; 31(10). PMID: 23011617    Free PMC article.
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, +12 authors, Norman Wolmark.
N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335
Highly Cited.
Shear wave elastography of breast cancer: Sensitivity according to histological type in a large cohort.
Andrew Evans, Yee Ting Sim, +3 authors, Sarah J Vinnicombe.
Breast, 2016 Mar 29; 26. PMID: 27017250
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management].
Elisabeth Luporsi, Jean-Pierre Bellocq, +15 authors, Institut National du Cancer.
Bull Cancer, 2015 Aug 04; 102(9). PMID: 26235416
Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors.
Xiao-Li Cao, Wei Bao, +5 authors, Jie Xue.
Ultrasound Med Biol, 2013 Nov 12; 40(1). PMID: 24207087
Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue.
Steven J Potts, Joseph S Krueger, +4 authors, Holger Lange.
Lab Invest, 2012 Jul 18; 92(9). PMID: 22801299
Equivalence of MammaPrint array types in clinical trials and diagnostics.
Inès Beumer, Anke Witteveen, +11 authors, Annuska Glas.
Breast Cancer Res Treat, 2016 Mar 24; 156(2). PMID: 27002507    Free PMC article.
Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer.
Daphne T Tsoi, Miho Inoue, +2 authors, Kathleen I Pritchard.
Oncologist, 2010 Apr 28; 15(5). PMID: 20421264    Free PMC article.
Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan.
Masahide Kondo, Shu Ling Hoshi, +2 authors, Masakazu Toi.
Breast Cancer Res Treat, 2007 Dec 14; 112(1). PMID: 18075786
Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?
Ping Tang, Kristin A Skinner, David G Hicks.
Diagn Mol Pathol, 2009 Aug 26; 18(3). PMID: 19704256
Review.
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
David Groheux, Mohamed Majdoub, +8 authors, Dimitris Visvikis.
Eur J Nucl Med Mol Imaging, 2015 Jul 05; 42(11). PMID: 26140849    Free PMC article.
Relationship between tumor heterogeneity measured on FDG-PET/CT and pathological prognostic factors in invasive breast cancer.
Michael Soussan, Fanny Orlhac, +4 authors, Irène Buvat.
PLoS One, 2014 Apr 12; 9(4). PMID: 24722644    Free PMC article.
Highly Cited.
Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Ruey-Feng Chang, Hong-Hao Chen, +3 authors, Chung-Ming Lo.
Magn Reson Imaging, 2016 Mar 13; 34(6). PMID: 26968141
Perfusion heterogeneity in breast tumors for assessment of angiogenesis.
Ying-Jia Li, Ge Wen, +7 authors, Ying-Shi Gu.
J Ultrasound Med, 2013 Jun 28; 32(7). PMID: 23804337
Screening miRNAs related to different subtypes of breast cancer with miRNAs microarray.
E-H Sun, Q Zhou, +5 authors, D-Y Ma.
Eur Rev Med Pharmacol Sci, 2014 Oct 24; 18(19). PMID: 25339470
The causes and consequences of genetic heterogeneity in cancer evolution.
Rebecca A Burrell, Nicholas McGranahan, Jiri Bartek, Charles Swanton.
Nature, 2013 Sep 21; 501(7467). PMID: 24048066
Highly Cited. Review.
Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
Ashley H Woodson, Kimberly I Muse, +11 authors, Jennifer K Litton.
Oncologist, 2014 Jun 22; 19(8). PMID: 24951607    Free PMC article.
Mutational processes molding the genomes of 21 breast cancers.
Serena Nik-Zainal, Ludmil B Alexandrov, +51 authors, Breast Cancer Working Group of the International Cancer Genome Consortium.
Cell, 2012 May 23; 149(5). PMID: 22608084    Free PMC article.
Highly Cited.
Chromogenic and fluorescent in situ hybridization in breast cancer.
Maryou B K Lambros, Rachael Natrajan, Jorge S Reis-Filho.
Hum Pathol, 2007 Jul 21; 38(8). PMID: 17640550
Review.
Measuring residual estrogen receptor availability during fulvestrant therapy in patients with metastatic breast cancer.
Michel van Kruchten, Elisabeth G de Vries, +7 authors, Geke A Hospers.
Cancer Discov, 2014 Nov 09; 5(1). PMID: 25380844
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Molecular cytogenetic analysis of breast cancer: a combined multicolor fluorescence in situ hybridization and G-banding study of uncultured tumor cells.
Angeliki D Ferti, Maria J Stamouli, +2 authors, Bryan D Young.
Cancer Genet Cytogenet, 2004 Apr 24; 149(1). PMID: 15104280
Digital breast tomosynthesis (3D-mammography) screening: A pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials.
Nehmat Houssami, Kristina Lång, +3 authors, Per Skaane.
Breast, 2016 Mar 29; 26. PMID: 27017251
Review.
Intratumor heterogeneity: seeing the wood for the trees.
Timothy A Yap, Marco Gerlinger, +2 authors, Charles Swanton.
Sci Transl Med, 2012 Mar 31; 4(127). PMID: 22461637
Highly Cited.
Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores.
Vandana Dialani, Shantanu Gaur, +5 authors, Priscilla J Slanetz.
Radiology, 2016 Mar 05; 280(2). PMID: 26937802
On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases.
George T Beatson.
Trans Med Chir Soc Edinb, 1896 Jan 01; 15. PMID: 29584099    Free PMC article.
Highly Cited.
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Dennis Vriens, Jonathan A Disselhorst, +2 authors, Eric P Visser.
Int J Radiat Oncol Biol Phys, 2012 Feb 15; 82(5). PMID: 22330998
Stromal gene expression predicts clinical outcome in breast cancer.
Greg Finak, Nicholas Bertos, +9 authors, Morag Park.
Nat Med, 2008 Apr 29; 14(5). PMID: 18438415
Highly Cited.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
Larissa A Korde, Lara Lusa, +7 authors, Jo Anne Zujewski.
Breast Cancer Res Treat, 2009 Dec 17; 119(3). PMID: 20012355    Free PMC article.
Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy.
Lindsey Enewold, Ann M Geiger, JoAnne Zujewski, Linda C Harlan.
Breast Cancer Res Treat, 2015 Apr 11; 151(1). PMID: 25859924
Sequence analysis of mutations and translocations across breast cancer subtypes.
Shantanu Banerji, Kristian Cibulskis, +44 authors, Matthew Meyerson.
Nature, 2012 Jun 23; 486(7403). PMID: 22722202    Free PMC article.
Highly Cited.
ER and PR immunohistochemistry and HER2 FISH versus oncotype DX: implications for breast cancer treatment.
MiHee M Park, Joshua J Ebel, Weiquiang Zhao, Debra L Zynger.
Breast J, 2013 Nov 23; 20(1). PMID: 24261318
Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer.
Rie Horii, Masaaki Matsuura, +2 authors, Futoshi Akiyama.
Breast Cancer, 2013 Jan 12; 21(5). PMID: 23307494
Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers.
Matthew W Conklin, Patricia J Keely.
Cell Adh Migr, 2012 May 10; 6(3). PMID: 22568982    Free PMC article.
Review.
Multi-gene fluorescence in situ hybridization to detect cell cycle gene copy number aberrations in young breast cancer patients.
Chunyan Li, Jingchao Bai, +9 authors, J Zhang.
Cell Cycle, 2014 Mar 14; 13(8). PMID: 24621502    Free PMC article.
Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers.
Xiaofeng Dai, Yang Li, Zhonghu Bai, Xu-Qing Tang.
Sci Rep, 2015 Sep 26; 5. PMID: 26404658    Free PMC article.
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, +3 authors, Ahmedin Jemal.
CA Cancer J Clin, 2015 Oct 30; 66(1). PMID: 26513636
Highly Cited.
Breast cancer circulating biomarkers: advantages, drawbacks, and new insights.
Andrea Ravelli, James M Reuben, +13 authors, Solid Tumor Working Party of European Blood and Marrow Transplantation Society (EBMT).
Tumour Biol, 2015 Aug 27; 36(9). PMID: 26307395
Review.
The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
Laura Kenny.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834108
Review.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, +28 authors, George W Sledge.
N Engl J Med, 2015 Sep 29; 373(21). PMID: 26412349    Free PMC article.
Highly Cited.
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection.
Lucia Hernandez, Paul M Wilkerson, +12 authors, Jorge S Reis-Filho.
J Pathol, 2012 Jan 19; 227(1). PMID: 22252965    Free PMC article.
Intratumoral heterogeneity of breast cancer xenograft models: texture analysis of diffusion-weighted MR imaging.
Bo La Yun, Nariya Cho, +6 authors, Woo Kyung Moon.
Korean J Radiol, 2014 Sep 24; 15(5). PMID: 25246820    Free PMC article.
Highly multiplexed subcellular RNA sequencing in situ.
Je Hyuk Lee, Evan R Daugharthy, +16 authors, George M Church.
Science, 2014 Mar 01; 343(6177). PMID: 24578530    Free PMC article.
Highly Cited.
Correlation between (18)F-FDG uptake on PET/CT and prognostic factors in triple-negative breast cancer.
Hye Ryoung Koo, Jeong Seon Park, +3 authors, Woo Kyung Moon.
Eur Radiol, 2015 Apr 24; 25(11). PMID: 25903708
Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
M Schena, D Shalon, R W Davis, P O Brown.
Science, 1995 Oct 20; 270(5235). PMID: 7569999
Highly Cited.
Heterogeneity of tumor cells from a single mouse mammary tumor.
D L Dexter, H M Kowalski, +3 authors, G H Heppner.
Cancer Res, 1978 Oct 01; 38(10). PMID: 210930
Highly Cited.
Genome evolution during progression to breast cancer.
Daniel E Newburger, Dorna Kashef-Haghighi, +10 authors, Arend Sidow.
Genome Res, 2013 Apr 10; 23(7). PMID: 23568837    Free PMC article.
Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.
Kejia Cai, He N Xu, +4 authors, Lin Z Li.
Mol Imaging Biol, 2014 May 09; 16(5). PMID: 24811957    Free PMC article.
Usefulness of lesion image mapping with multidetector-row helical computed tomography using a dedicated skin marker in breast-conserving surgery.
Narumi Harada-Shoji, Takayuki Yamada, +4 authors, Noriaki Ohuchi.
Eur Radiol, 2008 Nov 18; 19(4). PMID: 19011865
Underutilization of gene expression profiling for early-stage breast cancer in California.
Rosemary D Cress, Yingjia S Chen, +2 authors, Kenneth W Kizer.
Cancer Causes Control, 2016 Apr 22; 27(6). PMID: 27097910    Free PMC article.
Differences in Multi-Modal Ultrasound Imaging between Triple Negative and Non-Triple Negative Breast Cancer.
Ziyao Li, Jiawei Tian, +5 authors, Tong Wu.
Ultrasound Med Biol, 2016 Jan 21; 42(4). PMID: 26786891
Molecular Imaging of Biomarkers in Breast Cancer.
Gary A Ulaner, Chris C Riedl, +3 authors, Wolfgang Weber.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834103    Free PMC article.
Review.
A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers.
Xinyan Wu, Muhammad S Zahari, +6 authors, Akhilesh Pandey.
Cancer Biol Ther, 2014 Dec 24; 15(12). PMID: 25535895    Free PMC article.
Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis: Correlations With Detailed Pathological Findings.
Eun Sook Ko, Jae-Hun Kim, +3 authors, Seok Jin Nam.
Medicine (Baltimore), 2016 Jan 29; 95(3). PMID: 26817878    Free PMC article.
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer.
Michalina Janiszewska, Lin Liu, +12 authors, Kornelia Polyak.
Nat Genet, 2015 Aug 25; 47(10). PMID: 26301495    Free PMC article.
Highly Cited.
Breast cancer subtypes and the risk of local and regional relapse.
K David Voduc, Maggie C U Cheang, +3 authors, Hagen Kennecke.
J Clin Oncol, 2010 Mar 03; 28(10). PMID: 20194857
Highly Cited.
Cell-free circulating tumour DNA as a liquid biopsy in breast cancer.
Leticia De Mattos-Arruda, Carlos Caldas.
Mol Oncol, 2016 Jan 19; 10(3). PMID: 26776681    Free PMC article.
Review.
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay.
Elizabeth J Sutton, Jung Hun Oh, +5 authors, Elizabeth A Morris.
J Magn Reson Imaging, 2015 Apr 09; 42(5). PMID: 25850931    Free PMC article.
Highly Cited.
Assessing the extent of breast cancer using multidetector row helical computed tomography.
Kei Takase, Akihiko Furuta, +5 authors, Shoki Takahashi.
J Comput Assist Tomogr, 2006 Jun 17; 30(3). PMID: 16778625
Gene expression-based prognostic and predictive tools in breast cancer.
Gyöngyi Munkácsy, Marcell A Szász, Otilia Menyhárt.
Breast Cancer, 2015 Apr 16; 22(3). PMID: 25874688
Review.
Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response.
Ahmed Ashraf, Bilwaj Gaonkar, +4 authors, Despina Kontos.
Transl Oncol, 2015 Jun 10; 8(3). PMID: 26055172    Free PMC article.
The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients.
Salomon M Stemmer, Shmuel H Klang, +7 authors, Nicky Lieberman.
Breast Cancer Res Treat, 2013 Jun 27; 140(1). PMID: 23801158    Free PMC article.
Shear-wave elastographic features of breast cancers: comparison with mechanical elasticity and histopathologic characteristics.
Su Hyun Lee, Woo Kyung Moon, +8 authors, In-Ae Park.
Invest Radiol, 2013 Oct 31; 49(3). PMID: 24169069
Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors.
Gene Young Cho, Linda Moy, +5 authors, Eric E Sigmund.
Eur Radiol, 2015 Nov 30; 26(8). PMID: 26615557    Free PMC article.
Microarray-based RNA profiling of breast cancer: batch effect removal improves cross-platform consistency.
Martin J Larsen, Mads Thomassen, +2 authors, Torben A Kruse.
Biomed Res Int, 2014 Aug 08; 2014. PMID: 25101291    Free PMC article.
Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal.
CA Cancer J Clin, 2016 Jan 09; 66(1). PMID: 26742998
Highly Cited.
Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues.
Je Hyuk Lee, Evan R Daugharthy, +9 authors, George M Church.
Nat Protoc, 2015 Feb 13; 10(3). PMID: 25675209    Free PMC article.
Highly Cited.
Multidetector row helical computed tomography for invasive ductal carcinoma of the breast: correlation between radiological findings and the corresponding biological characteristics of patients.
Kentaro Tamaki, Takanori Ishida, +5 authors, Hironobu Sasano.
Cancer Sci, 2011 Oct 11; 103(1). PMID: 21981134
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases.
Gaetano Aurilio, Davide Disalvatore, +9 authors, Franco Nolè.
Eur J Cancer, 2013 Nov 26; 50(2). PMID: 24269135
Magnetic resonance imaging texture analysis classification of primary breast cancer.
S A Waugh, C A Purdie, +4 authors, A M Thompson.
Eur Radiol, 2015 Jun 13; 26(2). PMID: 26065395
The seed and soil hypothesis revisited: current state of knowledge of inherited genes on prognosis in breast cancer.
Nuria Ribelles, Angela Santonja, +2 authors, Emilio Alba.
Cancer Treat Rev, 2013 Oct 12; 40(2). PMID: 24112814
Review.
Tumour evolution inferred by single-cell sequencing.
Nicholas Navin, Jude Kendall, +12 authors, Michael Wigler.
Nature, 2011 Mar 15; 472(7341). PMID: 21399628    Free PMC article.
Highly Cited.
The role of HER2 in angiogenesis.
R Kumar, R Yarmand-Bagheri.
Semin Oncol, 2001 Nov 14; 28(5 Suppl 16). PMID: 11706393
Review.
Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
Lucy R Yates, Moritz Gerstung, +35 authors, Peter J Campbell.
Nat Med, 2015 Jun 23; 21(7). PMID: 26099045    Free PMC article.
Highly Cited.
Clonal evolution in breast cancer revealed by single nucleus genome sequencing.
Yong Wang, Jill Waters, +13 authors, Nicholas E Navin.
Nature, 2014 Aug 01; 512(7513). PMID: 25079324    Free PMC article.
Highly Cited.
Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.
Chen Chen, Zhilu Li, +3 authors, Shengchun Liu.
Cancer Biol Ther, 2015 May 23; 16(6). PMID: 25996380    Free PMC article.
Is breast MRI helpful in the evaluation of inconclusive mammographic findings?
Linda Moy, Kristin Elias, +4 authors, Cecilia L Mercado.
AJR Am J Roentgenol, 2009 Sep 23; 193(4). PMID: 19770320
DNA sequencing with chain-terminating inhibitors.
F Sanger, S Nicklen, A R Coulson.
Proc Natl Acad Sci U S A, 1977 Dec 01; 74(12). PMID: 271968    Free PMC article.
Highly Cited.
Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography.
J M Y Willaime, F E Turkheimer, L M Kenny, E O Aboagye.
Phys Med Biol, 2012 Dec 22; 58(2). PMID: 23257054
Tapping the potential of quantum dots for personalized oncology: current status and future perspectives.
Chuang Chen, Jun Peng, +3 authors, Dai-Wen Pang.
Nanomedicine (Lond), 2012 Mar 06; 7(3). PMID: 22385199
Review.
The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Sohrab P Shah, Andrew Roth, +56 authors, Samuel Aparicio.
Nature, 2012 Apr 13; 486(7403). PMID: 22495314    Free PMC article.
Highly Cited.
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer.
Muhammed Murtaza, Sarah-Jane Dawson, +19 authors, Carlos Caldas.
Nat Commun, 2015 Nov 05; 6. PMID: 26530965    Free PMC article.
Highly Cited.
Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment.
Dario Livio Longo, Walter Dastrù, +4 authors, Silvio Aime.
Magn Reson Imaging, 2015 Apr 04; 33(6). PMID: 25839393
Quantum-dot-based immunofluorescent imaging of HER2 and ER provides new insights into breast cancer heterogeneity.
Chuang Chen, Jun Peng, +8 authors, Yan Li.
Nanotechnology, 2010 Jan 30; 21(9). PMID: 20110584
Multiparametric MR Imaging of Breast Cancer.
Habib Rahbar, Savannah C Partridge.
Magn Reson Imaging Clin N Am, 2015 Nov 29; 24(1). PMID: 26613883    Free PMC article.
Review.
Breast cancer intra-tumor heterogeneity.
Luciano G Martelotto, Charlotte K Y Ng, +2 authors, Jorge S Reis-Filho.
Breast Cancer Res, 2014 Jan 01; 16(3). PMID: 25928070    Free PMC article.
Highly Cited. Review.
Emergency medical genomes: a breakthrough application of precision medicine.
Stephen F Kingsmore, Josh Petrikin, Laurel K Willig, Erin Guest.
Genome Med, 2015 Aug 01; 7(1). PMID: 26229553    Free PMC article.
Multilayered, core/shell nanoprobes based on magnetic ferric oxide particles and quantum dots for multimodality imaging of breast cancer tumors.
Qiang Ma, Yuko Nakane, +6 authors, Takashi Jin.
Biomaterials, 2012 Aug 22; 33(33). PMID: 22906608
In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice.
Hiroshi Tada, Hideo Higuchi, Tomonobu M Wanatabe, Noriaki Ohuchi.
Cancer Res, 2007 Feb 07; 67(3). PMID: 17283148
Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives.
Lin-Wei Wang, Chun-Wei Peng, Chuang Chen, Yan Li.
Breast Cancer Res Treat, 2015 Apr 03; 151(1). PMID: 25833213    Free PMC article.
Review.
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
Marc Tischkowitz, Jean-Sébastien Brunet, +5 authors, William D Foulkes.
BMC Cancer, 2007 Jul 26; 7. PMID: 17650314    Free PMC article.
Highly Cited.
Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.
Hong-Mei Zheng, Chuang Chen, +5 authors, Sheng-Rong Sun.
Tumour Biol, 2015 Sep 20; 37(2). PMID: 26385773
DNA breaks and chromosome pulverization from errors in mitosis.
Karen Crasta, Neil J Ganem, +7 authors, David Pellman.
Nature, 2012 Jan 20; 482(7383). PMID: 22258507    Free PMC article.
Highly Cited.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Justin M Balko, Jennifer M Giltnane, +24 authors, Carlos L Arteaga.
Cancer Discov, 2013 Dec 21; 4(2). PMID: 24356096    Free PMC article.
Highly Cited.
Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography.
Norio Masumoto, Takayuki Kadoya, +6 authors, Morihito Okada.
Ultrasound Med Biol, 2016 Feb 21; 42(5). PMID: 26895755
Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.
Hitomi Iwasa, Kei Kubota, +2 authors, Akihito Nishioka.
Oncol Rep, 2014 Feb 19; 31(4). PMID: 24535214    Free PMC article.
The Impact of the Oncotype DX Breast Cancer Assay on Treatment Decisions for Women With Estrogen Receptor-Positive, Node-Negative Breast Carcinoma in Hong Kong.
Roland C Y Leung, Thomas C C Yau, +12 authors, Polly S Y Cheung.
Clin Breast Cancer, 2016 Apr 24; 16(5). PMID: 27105769
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study.
Jeff Wang, Fumi Kato, +6 authors, Hiroki Shirato.
PLoS One, 2015 Nov 26; 10(11). PMID: 26600392    Free PMC article.
Circulating tumor DNA as a liquid biopsy for cancer.
Ellen Heitzer, Peter Ulz, Jochen B Geigl.
Clin Chem, 2014 Nov 13; 61(1). PMID: 25388429
Highly Cited. Review.
Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment.
Elizabeth S McDonald, David A Mankoff, Robert H Mach.
J Nucl Med, 2016 Feb 03; 57 Suppl 1. PMID: 26834105
Review.
Semiconductor nanocrystals as fluorescent biological labels.
M Bruchez, M Moronne, +2 authors, A P Alivisatos.
Science, 1998 Sep 25; 281(5385). PMID: 9748157
Highly Cited.
Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.
Ai Amioka, Norio Masumoto, +5 authors, Morihito Okada.
Jpn J Clin Oncol, 2016 Feb 06; 46(4). PMID: 26848078    Free PMC article.
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression.
Erin Currin, Lanell M Peterson, +5 authors, Hannah M Linden.
J Natl Compr Canc Netw, 2016 Feb 07; 14(2). PMID: 26850484    Free PMC article.
Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironment.
Chun-Wei Peng, Xiu-Li Liu, +5 authors, Yan Li.
Biomaterials, 2011 Jan 26; 32(11). PMID: 21262536
Single-molecule fluorescence in situ hybridization: quantitative imaging of single RNA molecules.
Sunjong Kwon.
BMB Rep, 2013 Feb 26; 46(2). PMID: 23433107    Free PMC article.
Review.
The life history of 21 breast cancers.
Serena Nik-Zainal, Peter Van Loo, +47 authors, Breast Cancer Working Group of the International Cancer Genome Consortium.
Cell, 2012 May 23; 149(5). PMID: 22608083    Free PMC article.
Highly Cited.
Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.
John Hornberger, Leon E Cosler, Gary H Lyman.
Am J Manag Care, 2005 May 19; 11(5). PMID: 15898220
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C Davies, +11 authors, R Peto.
Lancet, 2011 Aug 02; 378(9793). PMID: 21802721    Free PMC article.
Highly Cited.
Dogma and inquisition in medicine. Breast cancer as a case study.
S Hellman.
Cancer, 1993 Apr 01; 71(7). PMID: 8453567
The extracellular matrix modulates the hallmarks of cancer.
Michael W Pickup, Janna K Mouw, Valerie M Weaver.
EMBO Rep, 2014 Nov 10; 15(12). PMID: 25381661    Free PMC article.
Highly Cited. Review.
Next generation sequencing applications for breast cancer research.
Roxana Cojocneanu Petric, Laura-Ancuta Pop, +4 authors, Ioana Berindan Neagoe.
Clujul Med, 2015 Nov 27; 88(3). PMID: 26609257    Free PMC article.
Review.
Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women.
Nan Xu, Fengliang Wang, Mingming Lv, Lu Cheng.
Biomed Pharmacother, 2015 Feb 11; 69. PMID: 25661361
Progress in the clinical detection of heterogeneity in breast cancer.
Jun-Long Song, Chuang Chen, Jing-Ping Yuan, Sheng-Rong Sun.
Cancer Med, 2016 Oct 25; 5(12). PMID: 27774765    Free PMC article.
Review.
Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.
V Ludovini, A Sidoni, +13 authors, M Colozza.
Breast Cancer Res Treat, 2003 Oct 24; 81(2). PMID: 14572158
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
Josh J Carlson, Joshua A Roth.
Breast Cancer Res Treat, 2013 Aug 27; 141(1). PMID: 23974828    Free PMC article.
Highly Cited. Systematic Review.
Tumour heterogeneity and cancer cell plasticity.
Corbin E Meacham, Sean J Morrison.
Nature, 2013 Sep 21; 501(7467). PMID: 24048065    Free PMC article.
Highly Cited. Review.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, +29 authors, Samuel Aparicio.
Nature, 2012 Apr 24; 486(7403). PMID: 22522925    Free PMC article.
Highly Cited.
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines.
Kristina Subik, Jin-Feng Lee, +8 authors, Ping Tang.
Breast Cancer (Auckl), 2010 Aug 11; 4. PMID: 20697531    Free PMC article.
Highly Cited.
Revealing the Complexity of Breast Cancer by Next Generation Sequencing.
John Verigos, Angeliki Magklara.
Cancers (Basel), 2015 Nov 13; 7(4). PMID: 26561834    Free PMC article.
Review.
Multispectral optoacoustic tomography of the human breast: characterisation of healthy tissue and malignant lesions using a hybrid ultrasound-optoacoustic approach.
Anne Becker, Max Masthoff, +8 authors, Moritz Wildgruber.
Eur Radiol, 2017 Aug 09; 28(2). PMID: 28786007
Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma.
Marco Lodrini, Annika Sprüssel, +7 authors, Hedwig E Deubzer.
Oncotarget, 2017 Nov 22; 8(49). PMID: 29156716    Free PMC article.
Overexpression of SYF2 promotes cell proliferation and correlates with poor prognosis in human breast cancer.
Feng Shi, Feng-Feng Cai, +7 authors, Zhi-Xian He.
Oncotarget, 2017 Nov 29; 8(51). PMID: 29179448    Free PMC article.
A hederagenin saponin isolated from Clematis ganpiniana induces apoptosis in breast cancer cells via the mitochondrial pathway.
Lin Cheng, Liang Shi, +6 authors, Qiang Ding.
Oncol Lett, 2018 Feb 13; 15(2). PMID: 29434869    Free PMC article.
Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer
Trang Lan Vu, Trang Thu Nguyen, Van Thi Hong Doan, Lan Thi Thuong Vo.
Asian Pac J Cancer Prev, 2018 Jul 28; 19(7). PMID: 30049201    Free PMC article.
Prognostic value of DKK2 from the Dickkopf family in human breast cancer.
You-Cheng Shao, Xiao-Cui Nie, +3 authors, Xiao-Yan Xu.
Int J Oncol, 2018 Oct 16; 53(6). PMID: 30320375    Free PMC article.
Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis.
Kai-Teng Cai, Cai-Xia Feng, +3 authors, Jin-Cai Zhong.
Mol Med Rep, 2018 Oct 16; 18(6). PMID: 30320391    Free PMC article.
Artichoke Polyphenols Sensitize Human Breast Cancer Cells to Chemotherapeutic Drugs via a ROS-Mediated Downregulation of Flap Endonuclease 1.
Anna Maria Mileo, Donato Di Venere, Stefania Mardente, Stefania Miccadei.
Oxid Med Cell Longev, 2020 Jan 31; 2020. PMID: 31998443    Free PMC article.
Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry.
David K Woolf, Sonia P Li, +10 authors, Vicky Goh.
Biomark Cancer, 2019 Jun 19; 11. PMID: 31210736    Free PMC article.
Expression of Krüppel-like factor 9 in breast cancer patients and its effect on prognosis.
Zirong Jiang, Zhiping Xu, +3 authors, Kaiyin Wang.
Oncol Lett, 2020 Jul 30; 20(2). PMID: 32724373    Free PMC article.
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.
Yujing Li, Beilei Zeng, +2 authors, Guosheng Ren.
PeerJ, 2019 Aug 10; 7. PMID: 31396458    Free PMC article.
Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases.
Xun Xi, Xing-Wei Huang, +3 authors, Fu-Lan Yang.
Oncol Lett, 2020 Oct 06; 20(5). PMID: 33014152    Free PMC article.
Identification of long-term survival-associated gene in breast cancer.
Shipeng Ning, Hui Li, +10 authors, Da Pang.
Aging (Albany NY), 2020 Oct 21; 12(20). PMID: 33080569    Free PMC article.
Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunohistochemical point of view.
Albert Gibert-Ramos, Carlos López, +5 authors, Marylène Lejeune.
Histochem Cell Biol, 2019 Jul 14; 152(3). PMID: 31300877
Review.
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression.
Mirco Masi, Enrico Garattini, +10 authors, Erica Buoso.
Oncogenesis, 2020 Dec 15; 9(12). PMID: 33311444    Free PMC article.
Progress in the clinical detection of heterogeneity in breast cancer.
Jun-Long Song, Chuang Chen, Jing-Ping Yuan, Sheng-Rong Sun.
Cancer Med, 2016 Oct 25; 5(12). PMID: 27774765    Free PMC article.
Review.